Oral suspensions on the FDA shortage list
6 listings · 1 in shortage · 0 resolved · 5 discontinuation notices
FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported
Every listing in this form
- Teglutik (Riluzole Oral Suspension)Currently in shortage · updated
- Xarelto (Rivaroxaban For Suspension)Discontinuation · updated
- Actidose Aqua (Activated Charcoal Oral Suspension)Discontinuation · updated
- Nitrofurantoin Oral SuspensionDiscontinuation · updated
- Emend (Aprepitant Oral Powder for Suspension)Discontinuation · updated
- Diuril (Chlorothiazide Oral Suspension)Discontinuation · updated
Questions
- How many oral suspensions are in shortage?
- As of Oct 24, 2026, FDA lists 6 listings in this form: 1 currently in shortage, 0 resolved and 5 with only discontinuation notices.
- Which oral suspensions were updated this week?
- None of them in the 7 days up to Oct 24, 2026.
- Does FDA list alternatives?
- No. FDA: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Ask your pharmacist or prescriber.
Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.
Source: FDA Drug Shortages ↗, checked Oct 24, 2026. Listings are grouped by the dosage form at the end of FDA’s listing name. Illustrations: AI-generated (Gemini), edited by plusbeauxjours.